Prevention of vision-threatening complications in diabetic retinopathy: Two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA

Onnisa Nanegrungsunk, Neil M. Bressler

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of reviewThe use of intravitreous antivascular endothelial growth factor to prevent center-involved diabetic macular edema (CI-DME) with vision loss and proliferative diabetic retinopathy (PDR) has been investigated and recently reported in two randomized clinical trials. Although both trials showed substantial superiority of aflibercept at preventing the development of vision-threatening complications (VTCs) of CI-DME or PDR compared with sham at 1 or 2 years, without a concomitant benefit in visual acuity outcomes, the interpretation of the results and its application to clinical practice resulted in two disparate opinions. In this review, we discuss these two trials including their similarities and differences, other relevant studies, and considerations regarding the interpretation and the application of these results into clinical practice.Recent findingsThe Diabetic Retinopathy Clinical Research Retina Network Protocol W and the PANORAMA study demonstrated significantly lower probabilities of developing CI-DME or PDR at 2 years with intravitreous aflibercept compared with sham in eyes with moderate (Protocol W) or moderately severe (PANORAMA) to severe non-PDR (NPDR). However, visual acuity outcomes were not different.SummaryAlthough intravitreous aflibercept injections reduce the risk of VTCs in eyes with moderate-to-severe NPDR, the absence of visual acuity benefits supports the need for four-year results.

Original languageEnglish (US)
Pages (from-to)590-598
Number of pages9
JournalCurrent opinion in ophthalmology
Volume32
Issue number6
DOIs
StatePublished - Nov 1 2021

Keywords

  • antivascular endothelial growth factor
  • center-involved diabetic macular edema
  • diabetic retinopathy
  • prevention
  • proliferative diabetic retinopathy

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Prevention of vision-threatening complications in diabetic retinopathy: Two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA'. Together they form a unique fingerprint.

Cite this